Sustained complete renal remission is a predictor of reduced mortality,chronic kidney disease and end-stage renal disease in lupus nephritis

Abstract

Objective

The objective of this paper is to identify the relationship between patients with lupus nephritis (LN) who achieve sustained complete renal remission (CR) and renal outcome and survival.

Methods

From a longitudinal cohort study we identified patients with LN with CR. We compared the outcomes of patients who achieved sustained CR for at least five years (Group A) with those less than five years (Group B). The outcomes were death, SLICC/ACR damage index (SDI), renal flare, end-stage renal disease (ESRD) or estimated glomerular filtration rate (eGFR) < 50 ml/min, and doubling of serum creatinine. Regression analyses were used to identify predictors of the outcomes.

Results

A total of 345 patients were identified, 132 patients in Group A and 213 patients in Group B. The duration of CR in Group A was 11.76 ± 7.34 years but only 1.24 ± 1.24 years in Group B (p < 0.001). Death, increasing renal SDI, renal flare, renal transplantation, ESRD or eGFR < 50 ml/min, and doubling of serum creatinine in Group A were significantly lower than Group B. Multivariable analysis revealed that Group A patients were at a lower risk of death (hazard ratio (HR) = 0.20; 95% confidence interval (CI), 0.07–0.61; p = 0.004), increasing renal SDI (HR = 0.41; 95% CI, 0.21–0.76; p = 0.01), developing ESRD or eGFR < 50 ml/min (HR = 0.27; 95% CI, 0.12–0.61; p = 0.001), and doubling of serum creatinine (HR = 0.29; 95% CI, 0.14–0.61; p = 0.001) compared with Group B.

Conclusion

Sustained CR for at least five years is a predictor of better prognosis in patients with LN.

Keywords

Sustained remission lupus nephritis mortality chronic kidney disease end-stage renal disease

Get full access to this article

View all access options for this article.

References

Rovin BH, Stillman I. Chapter 42: Kidney. In: Lahita R. (ed.) Systemic lupus erythematosus. 5th ed. San Diego, CA: Academic Press, 2011.

Hanly

O’Keeffe

et al.

The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatology (Oxford) 2016; 55: 252–262.

Korbet

Lewis

Schwartz

Reichlin

Evans

Rohde

. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 2000; 35: 904–914.

Chen

Korbet

Katz

Schwartz

Lewis

. Collaborative Study Group. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 2008; 3: 46–53.

Sidiropoulos

Kritikos

Boumpas

. Lupus nephritis flares. Lupus 2005; 14: 49–52.

Illei

Takada

Parkin

et al.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002; 46: 995–1002.

Moroni

Quaglini

Maccario

Banfi

Ponticelli

. “Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996; 50: 2047–2053.

Tan

Cohen

Fries

et al.

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

Gladman

Ibañez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.

10.

Gladman

Ginzler

Goldsmith

et al.

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

11.

Koo

Kim

Chin

. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis. Lupus 2016; 25: 3–11.

12.

Korbet

Lewis

. Collaborative Study Group. Severe lupus nephritis: The predictive value of a ≥50% reduction in proteinuria at 6 months. Nephrol Dial Transplant 2013; 28: 2313–2318.

13.

Morris

Canetta

Appel

. Impact of the ALMS and MAINTAIN trials on the management of lupus nephritis. Nephrol Dial Transplant 2013; 28: 1371–1376.

14.

Moroni

Gallelli

Quaglini

et al.

Withdrawal of therapy in patients with proliferative lupus nephritis: Long-term follow-up. Nephrol Dial Transplant 2006; 21: 1541–1548.

15.

Mejía-Vilet

Córdova-Sánchez

Arreola-Guerra

Morales-Buenrostro

Uribe-Uribe

Correa-Rotter

. Renal flare prediction and prognosis in lupus nephritis Hispanic patients. Lupus 2016; 25: 315–324.

16.

Barber

Geldenhuys

Hanly

. Sustained remission of lupus nephritis. Lupus 2006; 15: 94–101.

17.

Fernandes das Neves

Irlapati

Isenberg

. Assessment of long-term remission in lupus nephritis patients: A retrospective analysis over 30 years. Rheumatology (Oxford) 2015; 54: 1403–1407.

18.

Contreras

Pardo

Cely

et al.

Factors associated with poor outcomes in patients with lupus nephritis. Lupus 2005; 14: 890–895.

19.

Kim

Chae

Chin

. Glomerular filtration rate and proteinuria: Association with mortality and renal progression in a prospective cohort of a community-based elderly population. PLoS One 2014; 9: e94120–e94120.

20.

Baek

Kim

et al.

Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population. Nephrol Dial Transplant 2012; 27: 2284–2290.

21.

Reich

Gladman

Urowitz

et al.

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int 2011; 79: 914–920.

22.

Gordon

Jayne

Pusey

et al.

European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009; 18: 257–263.

23.

Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421–432.